A1 Issues In Influenza Vaccine Safety

Monday, March 28, 2011: 11:00 AM-12:00 PM
International Ballroom - West
Presenters in this workshop will review recent data on the safety of influenza vaccines. Data on the safety of the 2009 H1N1 pandemic vaccine, adverse events associated with southern hemisphere vaccine and the safety of adjuvanted vaccines will be reviewed.
Karen Broder

11:00 AM
Surveillance of Significant Adverse Events Temporally Associated with 2009 Pandemic Influenza A (H1N1) Vaccine In California
Catheryn Salibay, MPH; Melissa Dahlke, MPH; Jacqueline Chan, BS; Jonathan Strober, MD; Vi Nguyen, MPH; Eva Weinstein, MPH; Alvin Nelson El Amin, MD; Sandra Jo Hammer, MSN, MPH; Gwendolyn Hammer, PhD, MSN, APRN; Robert Schechter, MD; John Talarico, DO, MPH; Kathleen Harriman, PhD, MPH, RN; Carol Glaser, DVM, MD; Kathleen Winter, MPH, Epidemiology Supervisor, California Department of Public Health
11:20 AM
A Comparison of Vaccine Safety Between Adjuvanted and Unadjuvanted Inactivated 2009 H1N1 Influenza Vaccines In British Columbia, Canada and Washington State, USA
Charla A. (Chas) DeBolt, RN, MPH, Sr. Epidemiologist for Vaccine Preventable Diseases, Washington State Department of Health; Amy Schneeberg, MSc; Anthony Marfin, MD, MPH, MA; Samson Chan, MPH; David Patrick, MD, FRCPC, MHSc; Monika Naus, MD, MHSc, FRCPC, FACPM
11:40 AM
Adverse Events In Children Associated with 2010 Southern Hemisphere Seasonal Influenza Vaccine
Michael Greenberg, MD, MPH, Director of Clinical Development, CSL; Kristy Van Dinther, BPharm(Hons), MPH; Eugene Maraskovsky, PhD
See more of: Submissions